These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27181719)

  • 21. Human ES and iPS cells as cell sources for the treatment of Parkinson's disease: current state and problems.
    Hwang DY; Kim DS; Kim DW
    J Cell Biochem; 2010 Feb; 109(2):292-301. PubMed ID: 20014069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell therapy for Parkinson's disease.
    Fischbach GD; McKhann GM
    N Engl J Med; 2001 Mar; 344(10):763-5. PubMed ID: 11236783
    [No Abstract]   [Full Text] [Related]  

  • 23. Neuroscience. Fetal cells again?
    Holden C
    Science; 2009 Oct; 326(5951):358-9. PubMed ID: 19833936
    [No Abstract]   [Full Text] [Related]  

  • 24. Therapeutic potential of human adipose-derived stem cells in neurological disorders.
    Chang KA; Lee JH; Suh YH
    J Pharmacol Sci; 2014; 126(4):293-301. PubMed ID: 25409785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell Therapy for Parkinson's Disease.
    Morizane A; Takahashi J
    Neurol Med Chir (Tokyo); 2016; 56(3):102-9. PubMed ID: 26912295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parkinson's disease. Fetal implants put to the test.
    Gage FH
    Nature; 1993 Feb; 361(6411):405-6. PubMed ID: 8429879
    [No Abstract]   [Full Text] [Related]  

  • 27. Radical directions in Parkinson's disease.
    Fisher LJ; Gage FH
    Nat Med; 1995 Mar; 1(3):201-3. PubMed ID: 7585029
    [No Abstract]   [Full Text] [Related]  

  • 28. Rate of progression determines the clinical outcome after neural transplantation in Parkinson's disease.
    Linazasoro G
    Brain; 2006 Jul; 129(Pt 7):E48; author reply E49. PubMed ID: 16803834
    [No Abstract]   [Full Text] [Related]  

  • 29. Dopaminergic differentiation using pluripotent stem cells.
    Momčilović O; Montoya-Sack J; Zeng X
    J Cell Biochem; 2012 Dec; 113(12):3610-9. PubMed ID: 22807388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia.
    Carlsson T; Winkler C; Lundblad M; Cenci MA; Björklund A; Kirik D
    Neurobiol Dis; 2006 Mar; 21(3):657-68. PubMed ID: 16256359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization and criteria of embryonic stem and induced pluripotent stem cells for a dopamine replacement therapy.
    Cooper O; Parmar M; Isacson O
    Prog Brain Res; 2012; 200():265-76. PubMed ID: 23195423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical neurotransplantation protocol for Huntington's and Parkinson's disease.
    Lopez WO; Nikkhah G; Kahlert UD; Maciaczyk D; Bogiel T; Moellers S; Schültke E; Döbrössy M; Maciaczyk J
    Restor Neurol Neurosci; 2013; 31(5):579-95. PubMed ID: 23777636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopaminergic transplantation for Parkinson's disease: current status and future prospects.
    Olanow CW; Kordower JH; Lang AE; Obeso JA
    Ann Neurol; 2009 Nov; 66(5):591-6. PubMed ID: 19938101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trials offer way forward for Parkinson's.
    Abbott A
    Nature; 2001 Mar; 410(6827):401. PubMed ID: 11260676
    [No Abstract]   [Full Text] [Related]  

  • 35. Fetal trials need public funds.
    Nature; 2003 Aug; 424(6952):981. PubMed ID: 12944924
    [No Abstract]   [Full Text] [Related]  

  • 36. Ontogenesis of embryonic porcine ventral mesencephalon in the perspective of its potential use as a xenograft in Parkinson's disease.
    Molenaar GJ; Hogenesch RI; Sprengers ME; Staal MJ
    J Comp Neurol; 1997 May; 382(1):19-28. PubMed ID: 9136809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The future of cell-based transplantation therapies for neurodegenerative disorders.
    Lazic SE; Barker RA
    J Hematother Stem Cell Res; 2003 Dec; 12(6):635-42. PubMed ID: 14977473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The application of iPSCs in Parkinson's disease.
    Jarbæk Nielsen JJ; Lillethorup TP; Glud AN; Hedemann Sørensen JC; Orlowski D
    Acta Neurobiol Exp (Wars); 2020; 80(3):273-285. PubMed ID: 32990285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histological analysis of fetal dopamine cell suspension grafts in two patients with Parkinson's disease gives promising results.
    Kirik D; Björklund A
    Brain; 2005 Jul; 128(Pt 7):1478-9. PubMed ID: 15980119
    [No Abstract]   [Full Text] [Related]  

  • 40. Transplantation of embryonic dopamine neurons for severe Parkinson's disease.
    Freed CR; Greene PE; Breeze RE; Tsai WY; DuMouchel W; Kao R; Dillon S; Winfield H; Culver S; Trojanowski JQ; Eidelberg D; Fahn S
    N Engl J Med; 2001 Mar; 344(10):710-9. PubMed ID: 11236774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.